Literature DB >> 22473130

Integration of FDG-PET/CT into external beam radiation therapy planning: technical aspects and recommendations on methodological approaches.

D Thorwarth1, T Beyer, R Boellaard, D de Ruysscher, A Grgic, J A Lee, U Pietrzyk, B Sattler, A Schaefer, W van Elmpt, W Vogel, W J G Oyen, U Nestle.   

Abstract

UNLABELLED: This work addresses the clinical adoption of FDG-PET/CT for image-guided radiation therapy planning (RTP). As such, important technical and methodological aspects of PET/CT-based RTP are reviewed and practical recommendations are given for routine patient management and clinical studies. First, recent developments in PET/CT hardware that are relevant to RTP are reviewed in the context of quality control and system calibration procedures that are mandatory for a reproducible adoption of PET/CT in RTP. Second, recommendations are provided on image acquisition and reconstruction to support the standardization of imaging protocols. A major prerequisite for routine RTP is a complete and secure data transfer to the actual planning system. Third, state-of-the-art tools for image fusion and co-registration are discussed briefly in the context of PET/CT imaging pre- and post-RTP. This includes a brief review of state-of-the-art image contouring algorithms relevant to PET/CT-guided RTP. Finally, practical aspects of clinical workflow and patient management, such as patient setup and requirements for staff training are emphasized. PET/CT-guided RTP mandates attention to logistical aspects, patient set-up and acquisition parameters as well as an in-depth appreciation of quality control and protocol standardization.
CONCLUSION: Upon fulfilling the requirements to perform PET/CT for RTP, a new dimension of molecular imaging can be added to traditional morphological imaging. As a consequence, PET/CT imaging will support improved RTP and better patient care. This document serves as a guidance on practical and clinically validated instructions that are deemed useful to the staff involved in PET/CT-guided RTP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22473130     DOI: 10.3413/Nukmed-0455-11-12

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  13 in total

Review 1.  Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities.

Authors:  Wouter van Elmpt; Catharina M L Zegers; Marco Das; Dirk De Ruysscher
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

2.  Guidance on the use of PET for treatment planning in radiotherapy clinical trials.

Authors:  Lucy C Pike; Christopher M Thomas; Teresa Guerrero-Urbano; Andriana Michaelidou; Tony Greener; Elizabeth Miles; David Eaton; Sally F Barrington
Journal:  Br J Radiol       Date:  2019-08-23       Impact factor: 3.039

Review 3.  Current role of FDG PET/CT in lymphoma.

Authors:  Lale Kostakoglu; Bruce D Cheson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-12       Impact factor: 9.236

4.  PET-based delineation of tumour volumes in lung cancer: comparison with pathological findings.

Authors:  Andrea Schaefer; Yoo Jin Kim; Stephanie Kremp; Sebastian Mai; Jochen Fleckenstein; Hendrik Bohnenberger; Hans-Joachim Schäfers; Jan-Martin Kuhnigk; Rainer M Bohle; Christian Rübe; Carl-Martin Kirsch; Aleksandar Grgic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-30       Impact factor: 9.236

5.  Developing quality assurance tests for simultaneous Positron Emission Tomography - Magnetic Resonance imaging for radiotherapy planning.

Authors:  Jonathan J Wyatt; Hazel M McCallum; Ross J Maxwell
Journal:  Phys Imaging Radiat Oncol       Date:  2022-04-20

6.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Authors:  Ronald Boellaard; Roberto Delgado-Bolton; Wim J G Oyen; Francesco Giammarile; Klaus Tatsch; Wolfgang Eschner; Fred J Verzijlbergen; Sally F Barrington; Lucy C Pike; Wolfgang A Weber; Sigrid Stroobants; Dominique Delbeke; Kevin J Donohoe; Scott Holbrook; Michael M Graham; Giorgio Testanera; Otto S Hoekstra; Josee Zijlstra; Eric Visser; Corneline J Hoekstra; Jan Pruim; Antoon Willemsen; Bertjan Arends; Jörg Kotzerke; Andreas Bockisch; Thomas Beyer; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-02       Impact factor: 9.236

Review 7.  Functional imaging for radiotherapy treatment planning: current status and future directions-a review.

Authors:  D Thorwarth
Journal:  Br J Radiol       Date:  2015-04-01       Impact factor: 3.039

8.  Multimodality functional imaging using DW-MRI and 18F-FDG-PET/CT during radiation therapy for human papillomavirus negative head and neck squamous cell carcinoma: Meixoeiro Hospital of Vigo Experience.

Authors:  David Aramburu Núñez; Antonio Lopez Medina; Moisés Mera Iglesias; Francisco Salvador Gomez; Abhay Dave; Vaios Hatzoglou; Ramesh Paudyal; Alfonso Calzado; Joseph O Deasy; Amita Shukla-Dave; Victor M Muñoz
Journal:  World J Radiol       Date:  2017-01-28

Review 9.  Value of PET imaging for radiation therapy.

Authors:  Constantin Lapa; Ursula Nestle; Nathalie L Albert; Christian Baues; Ambros Beer; Andreas Buck; Volker Budach; Rebecca Bütof; Stephanie E Combs; Thorsten Derlin; Matthias Eiber; Wolfgang P Fendler; Christian Furth; Cihan Gani; Eleni Gkika; Anca-L Grosu; Christoph Henkenberens; Harun Ilhan; Steffen Löck; Simone Marnitz-Schulze; Matthias Miederer; Michael Mix; Nils H Nicolay; Maximilian Niyazi; Christoph Pöttgen; Claus M Rödel; Imke Schatka; Sarah M Schwarzenboeck; Andrei S Todica; Wolfgang Weber; Simone Wegen; Thomas Wiegel; Constantinos Zamboglou; Daniel Zips; Klaus Zöphel; Sebastian Zschaeck; Daniela Thorwarth; Esther G C Troost
Journal:  Strahlenther Onkol       Date:  2021-07-14       Impact factor: 3.621

10.  Radiotherapy Planning and Molecular Imaging in Lung Cancer.

Authors:  Angelina Filice; Massimiliano Casali; Patrizia Ciammella; Marco Galaverni; Federica Fioroni; Cinzia Iotti; Annibale Versari
Journal:  Curr Radiopharm       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.